Tatva Chintan Q1 FY27 profit doubles; revenue up 43%

Key takeaway from the June quarter

Tatva Chintan Pharma Chem Ltd. reported a sharply stronger June quarter, with higher revenue and a meaningful improvement in profitability metrics compared with the year-ago period. The company’s consolidated net profit more than doubled, supported by a jump in operating performance and margin expansion. The results were approved by the board at a meeting held on 17 July 2026, which is also listed as the last earnings date for Q1 FY26-27.

Alongside the reported quarter, the company has also indicated the next reporting milestone. The upcoming earnings date for Q2 FY26-27 is 19 October 2026, as stated in multiple updates.

Earnings dates investors are tracking

Tatva Chintan’s Q1 FY26-27 earnings are marked to 17 July 2026. The company is scheduled to report Q2 FY26-27 results on 19 October 2026. These dates matter for shareholders because they frame when updated information on volumes, margins and profitability will be available.

In recent updates, the company is described as set to report “Q2, 2027 results” on 19 October 2026. In the context provided, this aligns with Q2 FY26-27 as the upcoming earnings window.

Q1 FY27 consolidated performance: profit and revenue

For Q1 FY27 (quarter ended 30 June 2026), consolidated total income from operations was reported at ₹167.055 crore, up from ₹116.864 crore in the same quarter last year. Consolidated profit after tax (PAT) was ₹15.981 crore versus ₹6.651 crore a year earlier.

The same dataset shows basic EPS of ₹6.83 for Q1 FY27 compared with ₹2.84 for Q1 FY26. Total comprehensive income for the June 2026 quarter was ₹15.662 crore versus ₹7.261 crore in the June 2025 quarter.

A separate performance summary in the provided text describes the quarter as a “strong start to FY27” and cites revenue from operations rising 43% year-on-year to about ₹167 crore from about ₹116.8 crore, with net profit around ₹16 crore compared with about ₹7 crore in the year-ago period.

Operating performance: EBITDA growth and margins

Operating leverage was visible in the EBITDA line. Tatva Chintan reported EBITDA of about ₹32.3 crore for Q1 FY27, up 86% year-on-year, while another line item cites EBITDA rising to ₹32.1 crore from ₹17.2 crore.

Margins also improved. EBITDA margin is stated to have increased to 19.2% from 14.7%, indicating a stronger profitability profile in the quarter than the previous year’s period.

Alternate revenue and gross profit snapshot shown in the data

The dataset also includes a separate snapshot showing “Revenue 146” with QoQ growth of 10.58% and YoY growth of 34.37%. It further lists “Gross Profit 13” with QoQ change of -19.79%.

In addition, the text states that Tatva Chintan “reported a net profit of Rs 10” and “revenue earned of Rs 146.” Since the same broader set of results also reports Q1 FY27 consolidated revenue around ₹167 crore and PAT around ₹16 crore, the ₹146 and ₹10 figures appear to be an alternate representation or a different scope in the source material. The numbers are included here as they are explicitly provided.

Standalone snapshot: Q1 FY27 vs Q4 FY26 and Q1 FY26

A standalone table for Q1 FY27 shows revenue of ₹150.74 crore, expenditure of ₹135.32 crore, and net profit of ₹10.45 crore. The same table states revenue grew 13.9% quarter-on-quarter and 36.4% year-on-year.

Net profit in that standalone view is shown up 15.8% versus the previous quarter and up 103.5% versus the year-ago quarter, indicating profit growth faster than revenue growth in the standalone business.

What prior-quarter disclosures show (Q2 FY26 and Q3 FY26)

Tatva Chintan had earlier announced unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, with board approval on 21 January 2026. For Q3 FY26, consolidated revenue is stated to have risen 52.90% year-on-year to ₹131.334 crore, while standalone revenue rose 65.00% to ₹138.588 crore.

The same Q3 FY26 note adds that the company achieved a turnaround in net profit on both consolidated and standalone bases versus prior year losses, while consolidated nine-month PAT declined by 17.99%.

For Q2 FY26 (quarter and half-year ended 30 September 2025), consolidated revenue from operations was ₹116.864 crore, PAT was ₹6.651 crore and EPS was ₹2.84. For H1 FY26, consolidated revenue was ₹242.543 crore with PAT of ₹16.568 crore and EPS of ₹7.25.

Market impact: what the numbers indicate (without forecasts)

The Q1 FY27 figures show a clear year-on-year step-up across revenue, EBITDA, EPS and net profit. The combination of higher revenue (₹167.055 crore) and higher EBITDA (about ₹32.3 crore) aligns with the reported margin expansion to 19.2%.

The provided updates also note that first quarter 2027 EPS and revenues exceeded analyst expectations, citing EPS at ₹6.83 versus ₹2.84 in 1Q 2026 and revenue at about ₹170 crore (₹1.70 billion) versus the year-ago baseline.

Key figures at a glance (consolidated)

Dates and select reported indicators

Why this quarter matters

Tatva Chintan’s Q1 FY27 results highlight a period where profitability rose faster than revenue, supported by the reported expansion in EBITDA margin. The consolidated profit growth is also reflected in the jump in EPS to ₹6.83.

At the same time, the presence of multiple numerical snapshots in the provided material (for example, revenue shown as ₹146 crore in one view and around ₹167 crore in consolidated results) makes it important for investors to focus on the scope being discussed, such as consolidated versus standalone reporting.

What to watch next

The next major milestone is the Q2 FY26-27 results announcement scheduled for 19 October 2026. That update should provide the next set of quarterly numbers and help investors compare whether the higher revenue base and improved margins seen in Q1 FY27 sustained into the following quarter.